Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleOral transforming growth factor‐beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti‐tumor immunity.AuthorsChoi, Sung Hee; Myers, Jay Thomas; Tomchuck, Suzanne Louise; Bonner, Melissa; Eid, Saada; Kingsley, Daniel Tyler; VanHeyst, Kristen Ashley; Kim, Seong‐Jin; Kim, Byung‐Gyu; Huang, Alex Yee‐ChenPublicationCancer Communications, 2024, Vol 44, Issue 8, p884ISSN2523-3548Publication typeArticleDOI10.1002/cac2.12589